Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development
Jan Malek,
Melissa Newham,
Jo Seldeslachts and
Reinhilde Veugelers
No 18816, CEPR Discussion Papers from C.E.P.R. Discussion Papers
Abstract:
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms’ technology dimension using patent information, next to their position in product markets. This allows us to identify the identity of targets and acquirers (who), the timing of acquisitions along the R&D process (when), and which type of R&D projects changes hands in terms of technology novelty (what). The main results can be summarized as follows. First, most of the action in M&As is in early R&D stages, still far from product markets. Second, most of the early-stage projects that change hands are high-risk/high-gain novel projects. Third, the industry leaders in the product markets are rather inactive in acquiring those novel early-stage projects. The likely acquirers of such projects are small or pipeline firms. Our results put in perspective the narrative that large incumbents acquire small targets with low-risk projects close to product launch.
Date: 2024-02
References: Add references at CitEc
Citations:
Downloads: (external link)
https://cepr.org/publications/DP18816 (application/pdf)
CEPR Discussion Papers are free to download for our researchers, subscribers and members. If you fall into one of these categories but have trouble downloading our papers, please contact us at subscribers@cepr.org
Related works:
Working Paper: Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development (2024) 
Working Paper: Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development (2024) 
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:cpr:ceprdp:18816
Ordering information: This working paper can be ordered from
https://cepr.org/publications/DP18816
Access Statistics for this paper
More papers in CEPR Discussion Papers from C.E.P.R. Discussion Papers Centre for Economic Policy Research, 33 Great Sutton Street, London EC1V 0DX.
Bibliographic data for series maintained by ().